Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7846]

Inhibition of prmt5 by repurposing market drugs - a fresh therapeutic pathway for cancer treatment

Inhibition of prmt5 by repurposing market drugs - a fresh therapeutic pathway for cancer treatment

New gene editing tool helps zero in on small cancer-linked mutations

New gene editing tool helps zero in on small cancer-linked mutations

$FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma$

FDA grants accelerated approval to talquetamab-tgvs for relapsed or refractory multiple myeloma

CDK9 Inhibitors: A promising combination partner in treating haematological malignancies

CDK9 Inhibitors: A promising combination partner in treating haematological malignancies

FDA approves pralsetinib for non-small cell lung cancer with RET gene fusions

FDA approves pralsetinib for non-small cell lung cancer with RET gene fusions

Research suggests a new approach for treatment-resistant breast cancers

Research suggests a new approach for treatment-resistant breast cancers

A select group: study may bring improved therapy to preselected lung cancer patients

A select group: study may bring improved therapy to preselected lung cancer patients

Novel liquid metal nanoparticles for cancer photoimmunotherapy

Novel liquid metal nanoparticles for cancer photoimmunotherapy

New method to identify mutations in childhood brain tumours

New method to identify mutations in childhood brain tumours

AI model can help determine where a patient’s cancer arose

AI model can help determine where a patient’s cancer arose

More from ecancer